drugset / Trial / NCT01956279

Complementary Neurosteroid Intervention in Gulf War Illnesses (GWVI)

NCT01956279

Phase 2 Completed 170 enrolled VA Office of Research and Development
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will investigate the use of adjunctive pregnenolone for the following: 1. fatigue that has limited usual activity, 2. musculoskeletal pain involving 2 or more regions of the body and, 3. cognitive symptoms (memory, concentration, or attentional difficulties by self-report) in Veterans deployed to the Gulf War theatre of operations between 1990 and 1991.

Timeline

Start
2013-10-01
Primary completion
2018-10-10
Completion
2018-10-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregnenolone Other / unclassified 250 mg